A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection
โ Scribed by Guo-Rong Han; Min-Kai Cao; Wei Zhao; Hong-Xiu Jiang; Cui-Min Wang; Shu-Fen Bai; Xin Yue; Gen-Ju Wang; Xun Tang; Zhi-Xun Fang
- Book ID
- 116652446
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 597 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
One hundred eleven newborn infants born of Spanish hepatitis B surface antigen (HBsAg) carrier mothers were consecutively assigned to one of three treatment groups. Group A was treated with three or four doses of hepatitis B immune globulin (HBIG) in one of three different schedules. Group B receive
A randomized double-blind, placebo-controlled efficacy trial of hepatitis B immune globulin (HBIG) for prevention of the mother-to-infant transmitted HBsAg carrier state was conducted in Taiwan where the carrier rate in the general population is 15 to 20%. HBIG was given immediately after birth to i